Zwack Unicum Likoripari es Kereskedelmi Nyrt. (ZWACK)
Budapest Stock Exchange · Hungary · prices in HUF · close of 22 Oct 2026
Key indicators
| Last close | HUF 29,300.00 |
|---|---|
| 52-week range | 28,000.00 – 40,500.00 |
| Return, 1 month / 3 months | −22.9% / −24.5% |
| Return, 1 year / 3 years | −6.3% / +85.6% |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 22.6% |
| Worst drawdown (1 year) | -30.2% |
| Average daily value traded | 11.93M HUF |
| Dividend yield | 5.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Zwack Unicum Likoripari es Kereskedelmi Nyrt. is a Hungarian spirits producer based in Budapest. It makes and markets herbal bitters, most notably Unicum, along with fruit brandies, pálinka and other liqueurs. Its products are sold in Hungary and exported to several other countries, where they are distributed through retail chains, bars and restaurants. The company combines traditional recipes with modern bottling and distribution operations.
The shares are listed on the Budapest Stock Exchange in Hungary under the code ZWACK, and the price on this page is in Hungarian forint (HUF). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Zwack Unicum Likoripari es Kereskedelmi Nyrt. (ZWACK) trades on the Budapest Stock Exchange in Hungary. It last closed at HUF 29,300.00 on 22 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 19 of 42 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 6.3% and over the last three months it fell 24.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Budapest Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 40 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -16.5% | ||
| From 52-week high | -27.5% | ||
| Momentum | 39 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -24.5% | ||
| 6-month return | -16.3% | ||
| 12-month return, skipping the last month | 21.5% | ||
| Stability (higher is calmer) | 68 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 22.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.2% | ||
| Liquidity | 64 · Fair | Moderate trading activity. | |
| Average daily value traded | 11.93M HUF | ||
| Zero-volume days | 0.0% | ||
| Income | 68 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.3% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +1.0% |
|---|---|
| 1 month | −22.9% |
| 3 months | −24.5% |
| 6 months | −16.3% |
| 1 year | −6.3% |
| 3 years | +85.6% |
| 5 years | +141.8% |
Signals
| 50-day / 200-day average | 35,378.00 / 35,100.59 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1,034.76 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Jul 2026 | HUF 1,550.0000 |
| 22 Jul 2025 | HUF 1,500.0000 |
| 23 Jul 2024 | HUF 1,400.0000 |
| 18 Jul 2023 | HUF 1,700.0000 |
| 19 Jul 2022 | HUF 1,500.0000 |
| 20 Jul 2021 | HUF 700.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Budapest Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.